107 related articles for article (PubMed ID: 37991848)
21. Characterization of immunogenicity of avian influenza antigens encapsulated in PLGA nanoparticles following mucosal and subcutaneous delivery in chickens.
Alkie TN; Yitbarek A; Taha-Abdelaziz K; Astill J; Sharif S
PLoS One; 2018; 13(11):e0206324. PubMed ID: 30383798
[TBL] [Abstract][Full Text] [Related]
22. An intranasal vaccine comprising SARS-CoV-2 spike receptor-binding domain protein entrapped in mannose-conjugated chitosan nanoparticle provides protection in hamsters.
Tabynov K; Solomadin M; Turebekov N; Babayeva M; Fomin G; Yadagiri G; Renu S; Yerubayev T; Petrovsky N; Renukaradhya GJ; Tabynov K
Sci Rep; 2023 Jul; 13(1):12115. PubMed ID: 37495639
[TBL] [Abstract][Full Text] [Related]
23. Enhanced nasal mucosal delivery and immunogenicity of anti-caries DNA vaccine through incorporation of anionic liposomes in chitosan/DNA complexes.
Chen L; Zhu J; Li Y; Lu J; Gao L; Xu H; Fan M; Yang X
PLoS One; 2013; 8(8):e71953. PubMed ID: 23977186
[TBL] [Abstract][Full Text] [Related]
24. Respiratory mucosal vaccination of peptide-poloxamine-DNA nanoparticles provides complete protection against lethal SARS-CoV-2 challenge.
Sun S; Li E; Zhao G; Tang J; Zuo Q; Cai L; Xu C; Sui C; Ou Y; Liu C; Li H; Ding Y; Li C; Lu D; Zhang W; Luo P; Cheng P; Gao Y; Tu C; Pitard B; Rosenecker J; Wang B; Liu Y; Zou Q; Guan S
Biomaterials; 2023 Jan; 292():121907. PubMed ID: 36436305
[TBL] [Abstract][Full Text] [Related]
25. Intranasal immunization with O-2'-Hydroxypropyl trimethyl ammonium chloride chitosan nanoparticles loaded with Newcastle disease virus DNA vaccine enhances mucosal immune response in chickens.
Zhao K; Sun B; Shi C; Sun Y; Jin Z; Hu G
J Nanobiotechnology; 2021 Aug; 19(1):240. PubMed ID: 34380522
[TBL] [Abstract][Full Text] [Related]
26. Intranasal immunization with inactivated chlamydial elementary bodies formulated in VCG-chitosan nanoparticles induces robust immunity against intranasal Chlamydia psittaci challenge.
Zuo Z; Zou Y; Li Q; Guo Y; Zhang T; Wu J; He C; Eko FO
Sci Rep; 2021 May; 11(1):10389. PubMed ID: 34001988
[TBL] [Abstract][Full Text] [Related]
27. Intradermal immunization by Ebola virus GP subunit vaccines using microneedle patches protects mice against lethal EBOV challenge.
Liu Y; Ye L; Lin F; Gomaa Y; Flyer D; Carrion R; Patterson JL; Prausnitz MR; Smith G; Glenn G; Wu H; Compans RW; Yang C
Sci Rep; 2018 Jul; 8(1):11193. PubMed ID: 30046140
[TBL] [Abstract][Full Text] [Related]
28. Enhancing Mucosal Immune Response of Newcastle Disease Virus DNA Vaccine Using N-2-Hydroxypropyl Trimethylammonium Chloride Chitosan and N,O-Carboxymethyl Chitosan Nanoparticles as Delivery Carrier.
Zhao K; Han J; Zhang Y; Wei L; Yu S; Wang X; Jin Z; Wang Y
Mol Pharm; 2018 Jan; 15(1):226-237. PubMed ID: 29172532
[TBL] [Abstract][Full Text] [Related]
29. Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS-CoV-2.
Jung HE; Ku KB; Kang BH; Park JH; Kim HC; Kim KD; Lee HK
Antiviral Res; 2023 Aug; 216():105656. PubMed ID: 37327877
[TBL] [Abstract][Full Text] [Related]
30. ChAdOx1-S adenoviral vector vaccine applied intranasally elicits superior mucosal immunity compared to the intramuscular route of vaccination.
Cokarić Brdovčak M; Materljan J; Šustić M; Ravlić S; Ružić T; Lisnić B; Miklić K; Brizić I; Pribanić Matešić M; Juranić Lisnić V; Halassy B; Rončević D; Knežević Z; Štefan L; Bertoglio F; Schubert M; Čičin-Šain L; Markotić A; Jonjić S; Krmpotić A
Eur J Immunol; 2022 Jun; 52(6):936-945. PubMed ID: 35304741
[TBL] [Abstract][Full Text] [Related]
31. Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine.
Pitcovski J; Gruzdev N; Abzach A; Katz C; Ben-Adiva R; Brand-Shwartz M; Yadid I; Ratzon-Ashkenazi E; Emquies K; Israeli H; Haviv H; Rapoport I; Bloch I; Shadmon R; Eitan Z; Eliahu D; Hilel T; Laster M; Kremer-Tal S; Byk-Tennenbaum T; Shahar E
Vaccine; 2022 Feb; 40(8):1098-1107. PubMed ID: 35078662
[TBL] [Abstract][Full Text] [Related]
32. Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
Deschambault Y; Lynch J; Warner B; Tierney K; Huynh D; Vendramelli R; Tailor N; Frost K; Sajesh B; LeBlanc K; Layne C; Lin L; Tamming L; Beniac D; Booth S; Carpenter M; Safronetz D; Li X; Kobasa D; Cao J
J Virol; 2022 May; 96(9):e0038922. PubMed ID: 35412347
[TBL] [Abstract][Full Text] [Related]
33. Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.
Bowman KA; Stein D; Shin S; Ferbas KG; Tobin NH; Mann C; Fischinger S; Ollmann Saphire E; Lauffenburger D; Rimoin AW; Aldrovandi G; Alter G
mBio; 2022 Oct; 13(5):e0164722. PubMed ID: 36000735
[TBL] [Abstract][Full Text] [Related]
34. Modulation of immunogenicity and immunoprotection of mucosal vaccine against coxsackievirus B3 by optimizing the coadministration mode of lymphotactin adjuvant.
Yue Y; Xu W; Xiong S
DNA Cell Biol; 2012 Apr; 31(4):479-88. PubMed ID: 21988406
[TBL] [Abstract][Full Text] [Related]
35. Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity.
Cui Z; Han D; Sun X; Zhang M; Feng X; Sun C; Gu J; Tong C; Lei L; Han W
Appl Microbiol Biotechnol; 2015 Jan; 99(2):667-80. PubMed ID: 25381907
[TBL] [Abstract][Full Text] [Related]
36. Induction of systemic, mucosal, and cellular immunity against SARS-CoV-2 in mice vaccinated by trans-airway with a S1 protein combined with a pulmonary surfactant-derived adjuvant SF-10.
Kimoto T; Sakai S; Kameda K; Morita R; Takahashi E; Shinohara Y; Kido H
Influenza Other Respir Viruses; 2023 Mar; 17(3):e13119. PubMed ID: 36909295
[TBL] [Abstract][Full Text] [Related]
37. A Thermostable Oral SARS-CoV-2 Vaccine Induces Mucosal and Protective Immunity.
Bellier B; Saura A; Luján LA; Molina CR; Luján HD; Klatzmann D
Front Immunol; 2022; 13():837443. PubMed ID: 35281065
[TBL] [Abstract][Full Text] [Related]
38. Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain.
Shim BS; Stadler K; Nguyen HH; Yun CH; Kim DW; Chang J; Czerkinsky C; Song MK
Virol J; 2012 Sep; 9():215. PubMed ID: 22995185
[TBL] [Abstract][Full Text] [Related]
39. Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization.
Lapuente D; Fuchs J; Willar J; Vieira Antão A; Eberlein V; Uhlig N; Issmail L; Schmidt A; Oltmanns F; Peter AS; Mueller-Schmucker S; Irrgang P; Fraedrich K; Cara A; Hoffmann M; Pöhlmann S; Ensser A; Pertl C; Willert T; Thirion C; Grunwald T; Überla K; Tenbusch M
Nat Commun; 2021 Nov; 12(1):6871. PubMed ID: 34836955
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous Intramuscular And Intranasal Administration Of Chitosan Nanoparticles-Adjuvanted
Li Y; Wang C; Sun Z; Xiao J; Yan X; Chen Y; Yu J; Wu Y
Int J Nanomedicine; 2019; 14():8179-8193. PubMed ID: 31632026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]